Navigation Links
Seniors Can Be Heartened by New Study on Statins
Date:11/13/2008

Groundbreaking Research Finds Statins Cut Risk of Heart Attacks, Deaths

RESTON, Va., Nov. 13 /PRNewswire-USNewswire/ -- Cardiovascular Disease is the leading cause of death among Americans, costing our healthcare system hundreds of millions of dollars and causing untold suffering. Now there is new hope for preventing this fatal disease - even among those who weren't thought to be at risk.

A new study has found that millions of people could cut their risk of a heart attack, stroke and death by taking statins. The study, released at the American Medical Association's annual meeting this week, found the benefits even for people with low cholesterol and no major risk for heart disease.

"This is the kind of news that could really save lives," said Michelle Plasari, President of RetireSafe's Senior Center for Health and Security. "According to this study, even people who believe they are at low risk for a heart attack could benefit from taking statins. This could transform the way we prevent heart disease."

About half all heart attacks and strokes occur in people who do not have elevated cholesterol. This study showed that a daily dose of a statin called rosuvastatin can prevent heart attacks and deaths in that group - people who would not normally be treated for heart disease.

Patients in the study had normal cholesterol. But they had higher levels of C-reactive protein, a marker of inflammation that indicates a risk of heart disease.

"This study shows that even if you have low cholesterol levels, you aren't safe from heart disease," Plasari said.

According to the American Heart Association, Americans over the age of 65 are at the highest risk of developing heart disease. At this age, initial heart attacks tend to be more fatal than those suffered at a younger age.

The first step to protecting yourself from heart disease is maintaining a healthy lifestyle. This can include a balanced diet, weight loss, exerci
'/>"/>

SOURCE RetireSafe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
2. Soft Contact Lenses Do Not Lead to Myopic Creep in Children, Study Shows
3. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
4. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
5. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
6. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
7. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
8. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
9. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
10. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
11. Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...r 30 Health Robotics today announc...ans and product specifications,for a new and revol...trition", a new key component of its i.v. Room of ...HP (Booth # 114). , "I look forward to se...n,s blueprints and to find out if TPNstation appea...
(Date:11/30/2009)...ire/ -- Amoena USA Corporation, the worldwide lead...ring the 4th Annual Breast Cancer Survivors Cruise...urvivors and the people who helped them through th...the most inspirational story to tell. ,, As par... mothers who bravely endured treatments; women who...
(Date:11/30/2009)...0 Decision Resources, one of the w...g on pharmaceutical and healthcare issues, forecas...a will grow nine percent annually over the 2008 - ...This growth will be driven mainly by increased gov...f more-expensive therapies like pegylated interfer...
Breaking Medicine Technology:Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3Rheumatoid arthritis is associated with poor sleep in women 48397 1Caribbean coral reefs flattened 8781 1Caribbean coral reefs flattened 8781 2First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 1First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 2First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 3First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 4First Brain Training Consumers Guide Debunks Ten Brain Health Myths and Reviews 21 Products 48391 5
...5 ,Forest Laboratories, Inc. (NYSE: FRX ) and Ged...esults from a U.S. conducted randomized,double-bli... a novel,antipsychotic, in 389 schizophrenia patie...hange from baseline to Week 6 on the Positive and,...trated a nominally,statistically significant (i.e....
...es Inc. ("Knopp"),announced that the U.S. Food and...evelopment has granted orphan drug designation to ...l sclerosis (ALS). (Logo: http://www.newscom.com... now completing Phase 1 studies to evaluate the sa...ound in healthy human,subjects. Knopp expects to i...
Other Medicine Technology:Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 2Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 3Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia 4Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2
(Date:11/30/2009)... Nov. 30 Baxa Corporation is spons..."culture of safety" means in today,s pharmacy envi...ating a Culture of Safety in Pharmacy ," features ...their experiences with culture of safety, what it ... the role of technology in enabling or inhibiting ...
(Date:11/30/2009)...30 Reportlinker.com announces that...catalogue: ,, Gene Therapy - Worldwide Market ...reportlinker.com/p0164218/Gene-Therapy---Worldwide...e therapy promises to be one of the most important...hievements for curing disease have been achieved, ...
(Date:11/30/2009)...help delay progression and reduce expenses, resear... News) -- Medical care for osteoarthritis patients... according to a new study. , Of that amount, in... billion in out-of-pocket costs. Annual insurer co...ale patient. Women also have higher out-of-pocket ...
(Date:11/30/2009)...lls stack up , , MONDAY, Nov. 30 (Health...rough the U.S. Congress differ in a number of ways...n the number of uninsured Americans. , Legislat...er this month would expand coverage to 96 percent ...proposal to expand coverage to 94 percent of Ameri...
(Date:11/30/2009)... has released an online service that lets users lo...s is the first hosted service in the world that us.... Result, blazing fast performance even over slowe...ara, CA (PRWEB) November 30, 2009 -- ShowMyPC has ...rvice that uses the familiar Microsoft Remote Desk...
Breaking Medicine News(10 mins):Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2
... Coffee industry partners, JavaFit...or fresh roasted fortified coffee. , ...5, 2008 -- JavaFit Coffee, the first in caffeine a...ry will push the JavaFit brand into many househol...
...S, Nov. 25 ATS Medical, Inc.,(Nasdaq: ATSI ), m...ac surgery,products, announced today that it will ...h Care Conference at the New York Palace Hotel. M...ww.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , ...
...Calif., Nov. 25 Henry Mayo Newhall Memorial,Hospi... from the local City,Council to proceed with its $...velopment of a new patient wing and three new medi...nding Santa Clarita Valley and thus developed the ...
...SCO, Nov. 25 ECO2 Plastics, Inc.,(OTC Bulletin Bo... is changing,the way plastics are recycled, today ... letter from the US Food and Drug Administration (...ed plastic flake,to be used in food packaging appl...
..., R.I., Nov. 25 CVS Caremark,(NYSE: CVS ) annou...gesting,that influenza vaccinations can help reduc...ronic conditions. These findings will be presente...ng of the positive impact of influenza,vaccination...
..., Nov. 25 Astorino, an architecture,engineering, ...ong with their,affiliate company, fathom, applied ...on a VA campus, for the design of the new Veterans...cutting ceremony,on Tuesday, November 25, 2008 at ...
Other Medicine News:Health News:JavaFit, Distributors of Vitamin Infused Fresh Roasted Coffee, Announces Partnership With CLR Roasters 2Health News:ATS Medical to Participate at the 20th Annual Piper Jaffray Health Care Conference 2Health News:Henry Mayo Newhall Memorial Hospital to Proceed With Master Plan 2Health News:Henry Mayo Newhall Memorial Hospital to Proceed With Master Plan 3Health News:ECO2 Plastics, Inc. Receives Favorable FDA Opinion Letter Approving the Use of Its Recycled Plastic Flake in Food Packaging Applications 2Health News:ECO2 Plastics, Inc. Receives Favorable FDA Opinion Letter Approving the Use of Its Recycled Plastic Flake in Food Packaging Applications 3Health News:CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting 2Health News:Design Firm Taps Into Veterans' Subconscious to Aid in Designing First-of-its- Kind Recovery Center 2
Advanta™ ePTFE facial implants
Malar Implants
Surgiform® Chin Implants
ABL80 FLEX Blood Gas Analyzer
Medicine Products: